SCHEMBL3453544

SCHEMBL3453544

N#Cc1c(Cl)cccc1-n1cccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.74
MAPT P10636 2/20 0.74
CYP1A2 P05177 5/20 0.66
CYP2C19 P33261 5/20 0.66
CYP3A4 P08684 4/20 0.66
CYP2C9 P11712 4/20 0.66
CYP2D6 P10635 3/20 0.66
KDM4E B2RXH2 4/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
GAA P10253 3/20 0.47
NOTUM Q6P988 1/20 0.44
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.35
DYRK1A Q13627 1/20 0.35
MGLL Q99685 1/20 0.33
PSMB8 P28062 1/20 0.33
DPP4 P27487 1/20 0.33
PREP P48147 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10075587 0.77 ALDH1A1 (0.74) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4
SCHEMBL13824739 0.77 CYP1A2 (1.00) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4
SCHEMBL14760393 0.77 ALDH1A1 (0.74) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4
Dichlobenil SCHEMBL1701380 0.76 ALDH1A1 (0.55) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4
Dichlobenil SCHEMBL55606 0.76 ALDH1A1 (0.55) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4
SCHEMBL9289883 0.76 ALDH1A1 (0.50) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4
SCHEMBL21486448 0.74 KDM4E (1.00) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4
SCHEMBL2826949 0.74 CYP1A2 (0.57) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4
Dichlobenil SCHEMBL28232070 0.74 ALDH1A1 (0.53) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4
Dichlobenil SCHEMBL10737856 0.74 ALDH1A1 (0.53) ALDH1A1MAPTCYP1A2CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106674226-B Antifungal compounds substituted with heterocyclic derivatives 詹森药业有限公司 2020-05-26 CN disclosed
US-9975899-B2 Antifungal 5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzo-diazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives JANSSEN PHARMACEUTICA NV (BE) 2018-05-22 US disclosed
US-9975899-B2 Antifungal 5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzo-diazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives JANSSEN PHARMACEUTICA NV (BE) 2018-05-22 US disclosed
US-9975899-B2 Antifungal 5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzo-diazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives JANSSEN PHARMACEUTICA NV (BE) 2018-05-22 US disclosed
US-9637490-B2 Antifungal 5,6-dihydro-4-[(difluoroethyl)phenyl]-4H-pyrrolo[1,2-α][1,4]benzodiazepine and 4-(difluoroethyl)phenyl-6H-pyrrolo[1,2-α][1,4]benzodiazepine derivatives JANSSEN PHARMACEUTICA NV (BE) 2017-05-02 US disclosed
US-20170073348-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-03-16 US disclosed
US-20170073348-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-03-16 US disclosed
US-20170073348-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-03-16 US disclosed
US-9493468-B2 Antifungal 5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzo-diazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives JANSSEN PHARMACEUTICA NV (BE) 2016-11-15 US disclosed
US-9493468-B2 Antifungal 5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzo-diazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives JANSSEN PHARMACEUTICA NV (BE) 2016-11-15 US disclosed
WO-2012150305-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO- DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2012-11-08 WO disclosed
WO-2012084804-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2012-06-28 WO disclosed
WO-2011154298-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4-[(DIFLUOROETHYL)PHENYL]-4H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE AND 4-(DIFLUOROETHYL)PHENYL-6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2011-12-15 WO disclosed
US-7820650-B2 Antifungal 4-substituted 5,6-dihydro-4H-pyrrolo [1,2-a][1,4]benzodiazepines JANSSEN PHARMACEUTICA NV (BE) 2010-10-26 US disclosed
EP-1392691-B1 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO[1,2-A] [1,4] BENZODIAZEPINES JANSSEN PHARMACEUTICA NV (BE) 2009-05-20 EP disclosed
US-20070232593-A1 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO [1,2-a][1,4]BENZODIAZEPINES GILKERSON TERENCE 2007-10-04 US disclosed
US-7202240-B2 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines JANSSEN PHARMACEUTICA N.V. (BE) 2007-04-10 US disclosed
US-20040266756-A1 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines JANSSEN PHARMACEUTICA N.V. (BE) 2004-12-30 US disclosed
EP-1392691-A1 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4 u H /u -PYRROLO 1,2-A] 1,4]BENZODIAZEPINES JANSSEN PHARMACEUTICA N.V. (BE) 2004-03-03 EP disclosed
WO-2002034752-A1 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO[1,2-A][1,4]BENZODIAZEPINES JANSSEN PHARMACEUTICA N.V. (BE) 2002-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232593-A1 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO [1,2-a][1,4]BENZODIAZEPINES GABBR1, HRH4, CYP8B1 ALDH1A1 903/4885MAPT 3016/4885CYP1A2 23/4885
US-20040266756-A1 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines CYP1B1, CBR1, CYP2E1 ALDH1A1 459/4885MAPT 2627/4885CYP1A2 16/4885
US-20170073348-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES GABBR1, HRH4, CYP1B1 ALDH1A1 410/4885MAPT 3640/4885CYP1A2 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.